Pharma's Trade Scorecard Looks Good – Except For That Big Biologics Blemish
This article was originally published in The Pink Sheet Daily
Executive Summary
Trans-Pacific Partnership will provide at least five years of data protection for biologics; other requirements could delay approval of biosimilars another 7 to 8 years.